Johnson & Johnson notifies Austria and Germany of $13.1 billion Shockwave deal (update*)
US pharma company Johnson & Johnson has sought approval in Austria and Germany to buy cardiovascular device supplier Shockwave Medical. The watchdogs have until May 27 to decide whether to approve...To view the full article, register now.
Already a subscriber? Click here to view full article